FDG-PET/CT Initial and Subsequent Therapy Evaluation : Progressing to PET/MR Imaging - 22/09/12
Corresponding author.Resumen |
Diagnostic imaging plays an important role in the staging, restaging, and treatment monitoring in head and neck cancer (HNC). MR imaging and computed tomography (CT) are the primary imaging modalities for the assessment of this type of tumor; however, they have been proved to be ineffective in some cases. 18F-2-fluoro-2-deoxy-D-glucose (FDG) PET/CT and more recently PET/MR imaging are increasingly becoming a standard part of the management of HNC. The purpose of this article is to discuss the indications and benefits of 18F-FDG PET/CT and PET/MR imaging in the management of patients with HNC.
El texto completo de este artículo está disponible en PDF.Keywords : Head and neck cancer, 18F-FDG, PET/CT, PET/MR imaging
Esquema
Vol 7 - N° 4
P. 369-380 - octobre 2012 Regresar al número
Artículo precedente
- [18F]Fluorodeoxyglucose-PET/Computed Tomography, PET, and Magnetic Resonance Imaging : Normal Anatomy, Pitfalls, and Artifacts
- Lina Mehta, Ryan T. Huber, Peter F. Faulhaber
- The Application of FDG-PET as Prognostic Indicators in Head and Neck Squamous Cell Carcinoma
- Farzan Siddiqui, Peter F. Faulhaber, Min Yao, Quynh-Thu Le
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?